溶血磷脂酸及其受体在肾纤维化中的研究进展

doi:10.3969/j.issn.1006-6233.2024.04.034

摘要
图/表
参考文献
相关文章 (9)

[1] Lin YH,Lin YC,Chen CC.Lysophosphatidic acid receptor antagonists and cancer:the current trends,clinical implications,and trials[J].Cells,2021,10(7):1629.
[2] Meduri B,Pujar GV,Durai Ananda Kumar T,et al.Lysophosphatidic acid (LPA) receptor modulators:Structural features and recent development[J].Eur Med Chem,2021,15(222):113574.
[3] Geng H,Lan R,Liu Y,et al.Proximal tubule LPA1 and LPA2 receptors use divergent signaling pathways to additively increase profibrotic cytokine secretion[J].Am Physiol Renal Physiol,2021,320(3):359-374.
[4] Geraldo LHM,Spohr TCLS,Amaral RFD,et al.Role of lysophosphatidic acid and its receptors in health and disease:novel therapeutic strategies[J].Signal Transduct Target Ther,2021,6(1):45.
[5] Xiang H,Lu Y,Shao M,et al.Lysophosphatidic acid receptors:biochemical and clinical implications in different diseases[J].Cancer,2020,11(12):3519-3535.
[6] Yang F,Chen GX.Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis[J].World Gastroenterol,2018,24(36):4132-4151.
[7] Suryadevara V,Ramchandran R,Kamp DW,et al.Lipid mediators regulate pulmonary fibrosis:potential mechanisms and signaling pathways[J].Int Mol Sci,2020,21(12):4257.
[8] Hecht JH,Weiner JA,Post SR,et al.Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex[J].Cell Biol,1996,135(4):1071-1083.
[9] Takagi Y,Nishikado S,Omi J,et al.The many roles of lysophospholipid mediators and Japanese contributions to this field[J].Biol Pharm Bull,2022,45(8):1008-1021.
[10] Lin YH,Lin YC,Chen CC.Lysophosphatidic acid receptor antagonists and cancer:the current trends,clinical implications,and trials[J].Cells,2021,10(7):1629.
[11] Lee GH,Cheon J,Kim D,et al.Lysophosphatidic acid promotes epithelial-mesenchymal transition in kidney epithelial cells via the LPAR1/MAPK-AKT/KLF5 signaling pathway in diabetic nephropathy[J].Int Mol Sci,2022,23(18):10497.
[12] Lee GH,Cheon J,Kim D,et al.Lysophosphatidic acid promotes epithelial-mesenchymal transition in kidney epithelial cells via the LPAR1/MAPK-AKT/KLF5 signaling pathway in diabetic nephropathy[J].Int Mol Sci,2022,23(18):10497.
[13] Rayego-Mateos S,Campillo S,Rodrigues-Diez RR,et al.Interplay between extracellular matrix components and cellular and molecular mechanisms in kidney fibrosis[J].Clin Sci (Lond),2021,135(16):1999-2029.
[14] Kuppe C,Ibrahim MM,Kranz J,et al.Decoding myofibroblast origins in human kidney fibrosis[J].Nature,2021,589(7841):281-286.
[15] Lee GH,Cheon J,Kim D,et al.Lysophosphatidic acid promotes epithelial-mesenchymal transition in kidney epithelial cells via the LPAR1/MAPK-AKT/KLF5 signaling pathway in diabetic nephropathy[J].Int Mol Sci,2022,23(18):10497.
[16] Peng F,Gong W,Li S,et al.circRNA_010383 acts as a sponge for miR-135a,and its downregulated expression contributes to renal fibrosis in diabetic nephropathy[J].Diabetes,2021,70(2):603-615.
[17] Saulnier-Blache JS,Feigerlova E,Halimi JM,et al.Urinary lysophopholipids are increased in diabetic patients with nephropathy[J].Diabetes Complications,2017,31(7):1103-1108.
[18] Kim D,Nam GY,Seo E,et al.Inhibition of ChREBP ubiquitination via the ROS/Akt-dependent downregulation of Smurf2 contributes to lysophosphatidic acid-induced fibrosis in renal mesangial cells[J].Biomed Sci,2022,29(1):31.
[19] Lee JH,Sarker MK,Choi H,et al.Lysophosphatidic acid receptor 1 inhibitor,AM095,attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase[J].Biochim Biophys Acta Mol Basis Dis,2019,1865(6):1332-1340.
[20] Lee GH,Cheon J,Kim D,et al.Lysophosphatidic acid promotes epithelial-mesenchymal transition in kidney epithelial cells via the LPAR1/MAPK-AKT/KLF5 signaling pathway in diabetic nephropathy[J].Int Mol Sci,2022,23(18):10497.
[21] Ni J,Yang F,Huang XR,Meng J,et al.Dual deficiency of angiotensin-converting enzyme-2 and Mas receptor enhances angiotensin Ⅱ-induced hypertension and hypertensive nephropathy[J].Cell Mol Med,2020,24(22):13093-13103.
[22] Hirata T,Smith SV,Takahashi T,et al.Increased levels of renal lysophosphatidic acid in rodent models with renal disease[J].Pharmacol Exp Ther,2021,376(2):240-249.
[23] Sakai N,Chun J,Duffield JS,et al.Lysophosphatidic acid signaling through its receptor initiates profibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor[J].Kidney Int,2017,91(3):628-641.
[24] Sakai N,Bain G,Furuichi K,et al.The involvement of autotaxin in renal interstitial fibrosis through regulation of fibroblast functions and induction of vascular leakage[J].Sci Rep,2019,9(1):7414.
[25] Mirzoyan K,Baiotto A,Dupuy A,et al.Increased urinary lysophosphatidic acid in mouse with subtotal nephrectomy:potential involvement in chronic kidney disease[J].Physiol Biochem,2016,72(4):803-812.